Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.125 GBX | 0.00% | -3.85% | -13.79% |
04-02 | EARNINGS: AdvancedAdvT hails "good progress" after Capita deal | AN |
03-28 | Earnings Flash (DEMG.L) DELTEX MEDICAL GROUP Posts FY23 Revenue GBP1.8M | MT |
Sales 2022 | 2.48M 3.11M 4.25M | Sales 2023 | 1.78M 2.23M 3.04M | Capitalization | 2.68M 3.36M 4.59M |
---|---|---|---|---|---|
Net income 2022 | -1M -1.25M -1.71M | Net income 2023 | -1M -1.25M -1.71M | EV / Sales 2022 | 3.53 x |
Net Debt 2022 | 1.76M 2.21M 3.02M | Net Debt 2023 | 1.22M 1.52M 2.08M | EV / Sales 2023 | 2.19 x |
P/E ratio 2022 |
-5.99
x | P/E ratio 2023 |
-1.34
x | Employees | 37 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 32.51% |
1 week | -3.85% | ||
Current month | +16.82% | ||
1 month | +13.64% | ||
3 months | -16.67% | ||
6 months | -19.35% | ||
Current year | -13.79% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Mears
CEO | Chief Executive Officer | 55 | 88-12-31 |
Natalie Wettler
DFI | Director of Finance/CFO | - | 21-05-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nigel Keen
CHM | Chairman | 77 | 87-12-31 |
Director/Board Member | - | 15-05-31 | |
Director/Board Member | 50 | 11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 0.125 | 0.00% | 260,687 |
24-05-01 | 0.125 | 0.00% | 107,559 |
24-04-30 | 0.125 | 0.00% | 350,000 |
24-04-29 | 0.125 | -7.41% | 3,653,545 |
24-04-26 | 0.135 | 0.00% | 104,139 |
Delayed Quote London S.E., May 02, 2024 at 11:35 am
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.79% | 2.96M | |
+3.59% | 3.48B | |
-5.85% | 174M | |
-14.17% | 82.89M | |
+31.88% | 60.13M |
- Stock Market
- Equities
- DEMG Stock